TY - JOUR
T1 - Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational corona database
AU - Aziz, Atiqullah
AU - May, Matthias
AU - Zigeuner, Richard
AU - Pichler, Martin
AU - Chromecki, Thomas
AU - Cindolo, Luca
AU - Schips, Luigi
AU - De Cobelli, Ottavio
AU - Rocco, Bernardo
AU - De Nunzio, Cosimo
AU - Tubaro, Andrea
AU - Coman, Ioan
AU - Truss, Michael
AU - Dalpiaz, Orietta
AU - Hoschke, Bernd
AU - Gilfrich, Christian
AU - Feciche, Bogdan
AU - Fenske, Fabian
AU - Sountoulides, Petros
AU - Figenshau, Robert S.
AU - Madison, Kerry
AU - Sánchez-Chapado, Manuel
AU - Del Carmen Santiago Martin, Maria
AU - Wieland, Wolf F.
AU - Salzano, Luigi
AU - Lotrecchiano, Giuseppe
AU - Waidelich, Raphaela
AU - Stief, Christian
AU - Brookman-May, Sabine
PY - 2014/2
Y1 - 2014/2
N2 - Purpose We analyzed the distinct clinicopathological features and prognosis of patients with renal cell carcinoma age 40 years or less compared to a reference group of patients 60 to 70 years old. Materials and Methods Overall 2,572 patients retrieved from a multicenter international database comprised of 6,234 patients with surgically treated renal cell carcinoma were included in this retrospective study. Clinical and histopathological features of 297 patients 40 years old or younger (4.8%) were compared to those of 2,275 patients (36.5%) 60 to 70 years old, who served as the reference group. Median followup was 59 months. The impact of young age and further parameters on disease specific mortality and all cause mortality was evaluated by multivariate Cox proportional hazards regression analyses. Results Young patients more frequently underwent nephron sparing surgery (27% vs 20%, p = 0.008) and regional lymph node dissection compared to older patients (38% vs 32%, p = 0.025). Organ confined tumor stage (81% vs 70%, p <0.001), smaller tumor diameter (4.5 vs 4.7 cm, p = 0.014) and chromophobe subtype (10% vs 4%, p <0.001) were significantly more frequent in young patients. On multivariate analysis older patients had a higher disease specific (HR 2.21, p <0.001) and all cause mortality (HR 3.05, p <0.001). The c indices for the Cox models were 0.87 and 0.78, respectively. However, integration of the variable age group did not significantly increase the predictive accuracy of the disease specific and all cause mortality models. Conclusions Young patients with renal cell carcinoma (40 years old or younger) have significantly different frequencies of clinical and histopathological features, and a significantly lower all cause and disease specific mortality compared to patients 60 to 70 years old.
AB - Purpose We analyzed the distinct clinicopathological features and prognosis of patients with renal cell carcinoma age 40 years or less compared to a reference group of patients 60 to 70 years old. Materials and Methods Overall 2,572 patients retrieved from a multicenter international database comprised of 6,234 patients with surgically treated renal cell carcinoma were included in this retrospective study. Clinical and histopathological features of 297 patients 40 years old or younger (4.8%) were compared to those of 2,275 patients (36.5%) 60 to 70 years old, who served as the reference group. Median followup was 59 months. The impact of young age and further parameters on disease specific mortality and all cause mortality was evaluated by multivariate Cox proportional hazards regression analyses. Results Young patients more frequently underwent nephron sparing surgery (27% vs 20%, p = 0.008) and regional lymph node dissection compared to older patients (38% vs 32%, p = 0.025). Organ confined tumor stage (81% vs 70%, p <0.001), smaller tumor diameter (4.5 vs 4.7 cm, p = 0.014) and chromophobe subtype (10% vs 4%, p <0.001) were significantly more frequent in young patients. On multivariate analysis older patients had a higher disease specific (HR 2.21, p <0.001) and all cause mortality (HR 3.05, p <0.001). The c indices for the Cox models were 0.87 and 0.78, respectively. However, integration of the variable age group did not significantly increase the predictive accuracy of the disease specific and all cause mortality models. Conclusions Young patients with renal cell carcinoma (40 years old or younger) have significantly different frequencies of clinical and histopathological features, and a significantly lower all cause and disease specific mortality compared to patients 60 to 70 years old.
KW - age factors
KW - carcinoma
KW - neoplasms by histologic type
KW - nephrectomy
KW - outcome assessment
KW - renal cell
UR - http://www.scopus.com/inward/record.url?scp=84891952366&partnerID=8YFLogxK
U2 - 10.1016/j.juro.2013.08.021
DO - 10.1016/j.juro.2013.08.021
M3 - Article
C2 - 23973516
AN - SCOPUS:84891952366
SN - 0022-5347
VL - 191
SP - 310
EP - 315
JO - Journal of Urology
JF - Journal of Urology
IS - 2
ER -